Bio Medica Laboratories IPO
Bio Medica Laboratories is an NSE SME IPO listed on the NSE SME platform, priced at ₹132–₹139 per share. The stock debuted at ₹111.2. The IPO had a lot size of ₹1000 shares and a minimum investment of ₹2,78,000.
Bio Medica Laboratories Limited IPO
- IPO Dates
- May 21, 2026 – May 25, 2026
- Price band
- ₹132-139 per equity share
- Minimum Investment
- ₹2,78,000
- Issue size
- ₹52.43 Cr
- Lot size
- 1000
- Allotment Date
- May 26, 2026
- Listing
- May 29, 2026
- Listing At
- NSE SME
IPO timeline
-
May 21, 2026
Open Date
Completed
-
May 25, 2026
Close Date
Completed
-
May 26, 2026
Allotment Date
Completed
-
May 29, 2026
Listing Date
Completed
Bio Medica Laboratories IPO Subscription Details
View Subscription DetailsBio Medica Laboratories IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Bio Medica Laboratories IPO Essentials
Bio Medica Laboratories IPO Details
Bio Medica Laboratories IPO is priced at ₹132-139 per share with a total issue size of 52.43 crore. The IPO has a lot size of 1000 shares and is listed on NSE SME.
- Issue price
- ₹132-139 per equity share
- Lot size
- 1000 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 37,72,000 shares(agg. up to ₹52.43 Cr)
- Total issue size
- 37,72,000 shares
(aggregating up to ₹52.43 crore) - Fresh issue
- 33,95,000 shares
(aggregating up to ₹47.19 crore) - Offer for sale (OFS)
- 3,77,000 shares
(aggregating up to ₹5.24 crore) - Listing at
- NSE SME
- List price
- 111.2
- Listing date
- Registrar
- Skyline Financial Services Pvt.Ltd.
- Lead manager
-
Narnolia Financial Services Ltd.
Market Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 2,000 | ₹2,78,000 |
| Individual(max) | 2 | 2,000 | ₹2,78,000 |
| sHNI(min) | 3 | 3,000 | ₹4,17,000 |
| sHNI(max) | 7 | 7,000 | ₹9,73,000 |
| sHNI(min) | 8 | 8,000 | ₹11,12,000 |
Bio Medica Laboratories IPO Reservation
Bio Medica Laboratories IPO reservation details show category-wise allocation of shares. Out of the total 3772000 shares, approximately 0.95% are reserved for QIB, 46.53% for NII, 47.51% for retail investors, and 5.01% for market maker.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Market Maker Shares Offered | 189000 (5.01%) | |
| QIB Shares Offered | 36000 (0.95%) | |
| NII (HNI) Shares Offered | 1755000 (46.53%) | |
| bHNI > ₹10L | 1170000 (30%) | 390 |
| sHNI < ₹10L | 585000 (15%) | 195 |
| Individual Shares Offered | 1792000 (47.51%) | 896 |
| Total Shares Offered | 3772000 (100%) |
Bio Medica Laboratories IPO Analytics
Bio Medica Laboratories IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Bio Medica Laboratories IPO Subscription Status
Bio Medica Laboratories IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 2.31x, indicating moderate demand across investor categories.
| As on | QIB |
NII
bHNI
sHNI
|
Individual | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 36,000 |
17,55,000
11,70,000
5,85,000
|
17,92,000 | 35,83,000 |
|
Day 1
21-05-26 05:00 PM
|
15.94 x |
0.03x
0.01x
0.06x
|
1.09 x | 0.72 x |
|
Day 2
22-05-26 05:00 PM
|
15.94 x |
0.39x
0.35x
0.46x
|
1.42 x | 1.06 x |
|
Day 3
25-05-26 05:00 PM
|
15.94 x |
1.41x
1.02x
2.19x
|
2.92 x | 2.31 x |
|
Total No. of Applications
|
bHNI | sHNI | Individual |
|---|---|---|---|
| 3076 (Approx) | 0.09x | 2.16x | 2.92x |
Bio Medica Laboratories Valuations
Earnings
- EPS Pre IPO
- ₹10.67/-
- EPS Post IPO
- ₹10.33/-
- P/E Pre IPO
- 13.03
- P/E Post IPO
- 13.45
Returns
- ROE
- 54.41%
- ROCE
- 23.22%
- RoNW
- 54.41%
- PAT Margin
- 30.35%
Fundamentals
- Debt / Equity
- 2.23
- Price / Book
- 8.66
- Market Cap
- ₹174.79 Cr.
Bio Medica Laboratories Financials( In Crs.)
| 30-Nov-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 65.17 | 39.12 | 19.53 | 17.57 |
| Revenue | 28.63 | 38.33 | 15.34 | 16.25 |
| Profit After Tax | 8.66 | 9.79 | 2.50 | 0.33 |
| Net Worth | 17.12 | 14.73 | 4.94 | 2.44 |
| Reserves & Surplus | 7.94 | 5.55 | 4.84 | 2.34 |
| Total Borrowing | 38.17 | 15.01 | 10.49 | 9.61 |
Bio Medica Laboratories Company & Offer Insights
About Bio Medica Laboratories
The Bio Medica Laboratories deals in the manufacture of parenteral formulations that involve the development and supply of ethical drug products, generics, and over-the-counter drugs in liquid and dry powder forms for injection purposes.
Product Portfolio:
58 products are present in liquid injectable forms
Dry powder injectable form of products is also supplied with 15 such products
It supplies various types of products like generic drugs, proprietary drugs, over the counter drugs, and others.
Business Model: The Bio Medica Laboratories function as a business to business organization dealing only in contract manufacturing of its products. It develops formulations of different products as per the requirements of various organizations. It is licensed for good manufacturing practices (GMP) and good laboratory practices (GLP) as certified by the Food & Drugs Administration, Madhya Pradesh.
Manufacturing plants: Two plants are located in Indore district of Madhya Pradesh.
Bio Medica Laboratories Promoter(s)
Mr. Mukesh Mehta, Mr. Pradeep Mehta are the company's promoters of Bio Medica Laboratories.
Bio Medica Laboratories IPO Issue Objectives
- •
- Repayment of Loan
- •
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
- •
- General Corporate Purposes
Contact Information
Contact Details
Bio Medica Laboratories
+91 7314102751
companysecretary@biomedica.co.in
Plot No. 11B-11C, Sector-E, Sanwer Road, Industrial Area, Industrial Estate (Indore), Indore, Madhya Pradesh - 452015.
Registrar Contact Details
Skyline Financial Services Private Ltd
02228511022
Frequently Asked Questions
Click any question to reveal the answer
Bio Medica Laboratories IPO is a book-built IPO worth ₹52.43 crore. The price band is ₹132–₹139 per share. The IPO opens on May 21, 2026 and closes on May 25, 2026. It will be listed on NSE SME Platform. Skyline Financial Services Pvt. Ltd. is the registrar.
The price band of Bio Medica Laboratories IPO is ₹132 to ₹139 per share.
The lot size of Bio Medica Laboratories IPO is 1000 shares.
The minimum investment for Bio Medica Laboratories IPO is approximately ₹2,78,000 based on the upper price band .
Bio Medica Laboratories IPO opens on May 21, 2026 and closes on May 25, 2026.
The allotment date of Bio Medica Laboratories IPO is May 26, 2026.
Bio Medica Laboratories IPO is expected to be listed on May 29, 2026, on NSE SME Platform.
Bio Medica Laboratories IPO valuation snapshot: P/E 13.45, EPS ₹10.33/-, P/B 8.66, RoNW 54.41%, and market cap ₹174.79 Cr.
To apply for Bio Medica Laboratories IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Bio Medica Laboratories IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Bio Medica Laboratories IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Bio Medica Laboratories IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Bio Medica Laboratories IPO allotment status on IPO Ji for quick and easy access.